Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

  1. Yubero, A.
  2. Barquín, A.
  3. Estévez, P.
  4. Pajares, B.
  5. Sánchez, L.
  6. Reche, P.
  7. Alarcón, J.
  8. Calzas, J.
  9. Gaba, L.
  10. Fuentes, J.
  11. Santaballa, A.
  12. Salvador, C.
  13. Manso, L.
  14. Herrero, A.
  15. Taus, Á.
  16. Márquez, R.
  17. Madani, J.
  18. Merino, M.
  19. Marquina, G.
  20. Casado, V.
  21. Constenla, M.
  22. Gutiérrez, M.
  23. Dosil, A.
  24. González-Martín, A.
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2022

Volume: 22

Issue: 1

Type: Article

DOI: 10.1186/S12885-022-10191-5 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus